You are here

Care Delivery


German researchers have developed a streamlined approach to histological examination using nano-scale computed tomography, according to a report published in the current issue of PNAS.

As the United States works to solve its ongoing opioid epidemic, medical specialties are beginning to examine their own behaviors to see who is, and is not, prescribing opioids. For example, a team of researchers used public Medicare data to study the number of opioids prescribed in 2015 by more than 2,000 radiologists from practices predominantly focused on interventional radiology.

Additional MR imaging performed during chemoradiation therapy could be an early predictor of a rectal cancer patient’s pathological response to treatment, according to research out of San Raffaele Hospital in Milan.

One of the largest open-source data sets of brain MRIs from stroke patients is now available for public download via Scientific Data, a team of University of Southern California scientists reported this week.

A nuclear imaging technique could detect recurrences of prostate cancer before routine testing, allowing clinicians and patients the chance to tackle metastasis before it becomes life-threatening, according to research out of the University of California, Los Angeles.


Recent Headlines

Noninvasive imaging system predicts breast cancer patients’ response to chemo

An optical imaging technique developed at Columbia University could predict neoadjuvant chemotherapy outcomes in breast cancer patients as early as two weeks after beginning treatment, researchers reported this week in Radiology.

Radiologists need patients—and vice versa

As long as you’re aware of what radiologists do, you only need to have been an imaging patient a time or two to appreciate how much value the specialty adds to U.S. healthcare. Personally, of course, I know what rads do because of my work. But I also have plenty of firsthand experience to draw from. Thinking back, I count four MRIs, two CTs, one diagnostic ultrasound and a dozen or so x-rays. At least. 

Cutting to the chase: How can radiologists best communicate test results?

Radiologists are often keen to avoid direct communication with primary providers, but referring clinicians actually prefer stronger connections, according to a study of 407 medical residents published in Academic Radiology.

Breast MRI screening associated with higher biopsy rates, lower cancer yield findings than mammography alone

Patients with and without a personal history of breast cancer (PHBC) have higher biopsy rates and lower cancer yields following biopsy in the 90 days after screening MRI than in the 90 days after a traditional mammogram, according to a new study published in JAMA Internal Medicine.

Is the eye the window to the brain? How gadolinium is changing the field of cerebrovascular imaging

Gadolinium could be doing a lot more for cerebrovascular patients than previously thought. According to a group of researchers at the National Institutes for Health, the chemical agent could highlight not just abnormalities in routine brain MRIs, but identify the severity of incident stroke.

Academic ER coverage: Why fix what’s not broken?

When should radiology replace its resident-based overnight model with 24-hour attending coverage? Perhaps never.

Allergic-like reactions to receiving injections of both ICM and GBCM are extremely rare

Allergic-like reactions to receiving both nonionic iodinated contrast medium (ICM) and gadolinium-based contrast medium (GBCM) are extremely rare, according to a new study published in the American Journal of Roentgenology. When such reactions did occur, they “presented as a mild acute reaction without significant clinical consequences.”

Do false-positive stereotactic-guided breast biopsies impact future screening adherence?

False-positive stereotactic vacuum-assisted breast biopsies (SVABs) do not negatively affect a patient’s future screening mammography adherence, according to a new study publishing by the Journal of the American College of Radiology.

FDA debuts domestic system for radioisotope production

The U.S. Food and Drug Administration (FDA) today approved imaging technology that will enable the domestic production of radioisotope Technetium-99 (Tc-99m), FDA Commissioner Scott Gottlieb, MD, has announced. The new tech will be known as the RadioGenix System.

Obstacle or death sentence? How women’s experiences shape views of breast cancer

A woman’s memories of breast cancer—whether they stem from a family member’s diagnosis or a close friend’s battle—could significantly shape that woman’s choices about her own preventive care, researchers reported in the Journal of Health Psychology.